Share Twitter LinkedIn Facebook Email Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
SGNTUC-024 Phase 1b/2 study: Tucatinib, trastuzumab, FOLFOX for HER2+ GI cancers Gastrointestinal 8 Mins Read
